Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05336643 | Radioisotope and Fluorescence Guidance in Rectal Cancer | unknown | N/A | 10 | University College, LondonOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05601388 | Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study | unknown | — | 60 | Sohag UniversityOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05446558 |
| Long-term Results in Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Colectomy |
| unknown |
| N/A |
| 140 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER |
| 1 |
| Oct 31, 2022 |
| clinicaltrials |
| NCT04278274 | Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer(MR-AI-pCR) | unknown | — | 205 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05587452 | Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence(RECOMMEND) | unknown | — | 950 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 24, 2022 | clinicaltrials |
| NCT02633098 | A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer(NeoART) | unknown | Phase 2 | 200 | St George's, University of LondonOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05575635 | Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC | unknown | Phase 2 | 40 | Henan Provincial People's HospitalOTHER | 0 | Oct 12, 2022 | clinicaltrials |
| NCT04331535 | The Genomic Medicine at VA Study(GenoVA) | unknown | N/A | 1,076 | Boston VA Research Institute, Inc.OTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT04801095 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 100 | Wellmarker BioINDUSTRY | 2 | Sep 16, 2022 | clinicaltrials |
| NCT05540951 | VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer | unknown | Phase 3 | 78 | Fudan UniversityOTHER | 1 | Sep 15, 2022 | clinicaltrials |
| NCT05530746 | Study on the Diagnostic Value of Multi-omics Combined Detection for Precancerous Lesions of CRC | unknown | — | 500 | Changhai HospitalOTHER | 1 | Sep 7, 2022 | clinicaltrials |
| NCT05031975 | Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy(ERASE-TMZ) | unknown | Phase 2 | 35 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT05526339 | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients | unknown | N/A | 600 | RenJi HospitalOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT04398446 | Effect of Hemp-CBD on Patients With CIPN(Coala-T-CBD) | unknown | Phase 2 | 56 | Main Line HealthOTHER | 1 | Sep 1, 2022 | clinicaltrials |
| NCT05524155 | Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Sep 1, 2022 | clinicaltrials |
| NCT05027737 | Early Ileostomy Closure for Rectal Cancer Patients in North America | unknown | N/A | 118 | Jewish General HospitalOTHER | 1 | Aug 23, 2022 | clinicaltrials |
| NCT05314101 | TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer | unknown | Phase 2 | 25 | Fujian Cancer HospitalOTHER_GOV | 1 | Aug 23, 2022 | clinicaltrials |
| NCT05510388 | HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients(HRISK) | unknown | N/A | 450 | RenJi HospitalOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05511051 | A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy | unknown | Phase 2 | 102 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT04966819 | Rectal Cancer Shared Care | unknown | N/A | 80 | Jewish General HospitalOTHER | 1 | Aug 19, 2022 | clinicaltrials |
| NCT04866108 | A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy | unknown | Phase 2 | 49 | Beijing Friendship HospitalOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05004831 | Fruquintinib Combined With TAS-102 in the Treatment of Patients With Advanced Metastatic CRC | unknown | Phase 2 | 54 | Sun Yat-sen UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT05016869 | Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 48 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04924179 | Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC | unknown | Phase 2 | 25 | Huazhong University of Science and TechnologyOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05495672 | Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules | unknown | N/A | 100 | Junjie PengOTHER | 1 | Aug 10, 2022 | clinicaltrials |
| NCT04598984 | The Role of Serum Adipokines in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer | unknown | — | 60 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04857203 | The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer | unknown | — | 60 | Istanbul Training and Research HospitalOTHER_GOV | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04127864 | Perioperative Immune Function in Patients Undergoing Colorectal Cancer Surgery(TruCulture) | unknown | — | 12 | University of CopenhagenOTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05482529 | Integrative Omics Analysis for Colorectal Cancer and Metastasis | unknown | — | 20 | fan liOTHER | 1 | Aug 1, 2022 | clinicaltrials |
| NCT04869956 | Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery | unknown | N/A | 50 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04733963 | Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer | unknown | Phase 2 | 112 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT04755907 | 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases | unknown | — | 120 | Peking Union Medical College HospitalOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT05451719 | Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy | unknown | Phase 2 | 116 | Fudan UniversityOTHER | 0 | Jul 12, 2022 | clinicaltrials |
| NCT05447715 | Fruquintinib Sequential BEV+FOLFIRI vs. BEV+FOLFIRI Sequential Fruquintinib in Metastatic Colorectal Cancer | unknown | Phase 2 | 134 | Weijian GuoOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT04628182 | The China Laparoscopic Right Hemicolectomy SNAPSHOT | unknown | — | 1,579 | Beijing Friendship HospitalOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05438108 | SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab in First-line Treatment of mCRC | unknown | Phase 2 | 30 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 29, 2022 | clinicaltrials |
| NCT05122221 | CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers | unknown | Phase 1 | 12 | Corregene Biotechnology Co., LtdINDUSTRY | 1 | Jun 28, 2022 | clinicaltrials |
| NCT03668431 | Dabrafenib + Trametinib + PDR001 In Colorectal Cancer | unknown | Phase 2 | 25 | Massachusetts General HospitalOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT04750772 | Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer | unknown | N/A | 60 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 27, 2022 | clinicaltrials |
| NCT05099211 | Neuromuscular Deconditioning and Reconditioning in Colon Cancer Patients: an APA Muscle Rendorcement Program(REMUSCLON) | unknown | N/A | 60 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05369312 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | unknown | Phase 1 | 230 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05423886 | The Effectiveness of Personalized Colorectal Cancer Screening Based on Fecal Hemoglobin Concentration(PERFECT-FIT) | unknown | N/A | 20,000 | Esther Toes-ZoutendijkOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05424939 | Management of Obstructive Colon Tumors in Istanbul | unknown | — | 500 | Istanbul Medipol University HospitalOTHER | 1 | Jun 21, 2022 | clinicaltrials |
| NCT04637048 | Observational Study on Patients With Hepatobiliary Tumors | unknown | — | 1,000 | Gang Chen, MDOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT05422547 | Role of Immunoscore® in Stage II-III Colorectal Cancer | unknown | — | 100 | D'Or Institute for Research and EducationOTHER | 1 | Jun 16, 2022 | clinicaltrials |
| NCT02588781 | Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02959541 | PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer | unknown | N/A | 48 | Vastra Gotaland RegionOTHER_GOV | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03947775 | HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | unknown | Phase 2 | 228 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03626922 | Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients | unknown | Phase 1 | 33 | NSABP Foundation IncNETWORK | 1 | Jun 10, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Nov 1, 2022source: clinicaltrials